US Patent 10738279 Modified NK-92 cells for treating cancer
Patent 10738279 was granted and assigned to NantKwest on August, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 10, 2016
Date of Patent
August 11, 2020
Patent Applicant
Patent Application Number
15531109
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10738279 Modified NK-92 cells for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.